Virpax Pharmaceuticals Inc (VRPX)
0.775
-0.02
(-3.12%)
USD |
NASDAQ |
May 17, 16:00
0.7928
+0.02
(+2.30%)
After-Hours: 20:00
Virpax Pharmaceuticals Shareholders Equity (Quarterly): -1.213M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.213M |
| December 31, 2023 | 1.934M |
| September 30, 2023 | 6.506M |
| June 30, 2023 | 12.30M |
| March 31, 2023 | 15.20M |
| December 31, 2022 | 16.58M |
| September 30, 2022 | 19.43M |
| June 30, 2022 | 26.92M |
| Date | Value |
|---|---|
| March 31, 2022 | 32.56M |
| December 31, 2021 | 37.48M |
| September 30, 2021 | 41.46M |
| June 30, 2021 | 7.536M |
| March 31, 2021 | 9.558M |
| December 31, 2020 | -4.216M |
| September 30, 2020 | -3.846M |
| December 31, 2019 | -2.732M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.216M
Minimum
Dec 2020
41.46M
Maximum
Sep 2021
13.47M
Average
10.93M
Median
Shareholders Equity (Quarterly) Benchmarks
| SINTX Technologies Inc | 9.926M |
| BioCryst Pharmaceuticals Inc | -476.17M |
| Bolt Biotherapeutics Inc | 104.16M |
| Scilex Holding Co | -189.79M |
| Coya Therapeutics Inc | 32.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.130M |
| Total Liabilities (Quarterly) | 4.344M |